Israel
Geneyx Genomex Ltd., headquartered in Israel, is a pioneering force in clinical genetic data analysis, positioning itself at the intersection of Big Data, Cloud Infrastructure, Health Care, and Information Technology. Founded in 2018, the company champions the slogan, "Better Data for Better Health," emphasizing its commitment to revolutionizing genomic interpretations for healthcare and research sectors.
Geneyx has developed a robust AI-powered SaaS platform that enhances genomic interpretation by automating the transformation of raw sequencing data into comprehensive clinical diagnostic reports. This innovative system, suitable for use in hospitals, genetic labs, universities, and pharmaceutical firms worldwide, integrates effortlessly with existing LIMS and EHR systems to streamline the diagnostic process.
The company secured a $10.00M Seed Round investment on 10 November 2021 from prominent investors such as Capri Ventures, Apple Core Holdings, Jonathan Karten, and Accenture Ventures, underscoring the confidence in its scalable, cutting-edge solutions.
